Export licence granted to Medlab in development of cannabis pain management products

Medlab Clinical ASX MDC cannabis export licence
Medlab has been granted a licence from the Office of Drug Control to export cannabis.

Australian life sciences company Medlab Clinical (ASX: MDC) has been granted a licence to export cannabis relating to the development of its NanaBis and NanaBidial cancer pain management medications.

Awarded by the national Office of Drug Control, the licence allows Medlab to legally supply cannabis overseas and will help progress the company’s trade discussions with foreign partners.

“The licence is a welcome addition to our other approvals,” said chief executive Dr Sean Hall.

“It will allow us to research, manufacture, trial and supply our products within Australia, as well as to foreign

... read more at: https://smallcaps.com.au/export-licence-granted-medlab-cannabis-pain-management-products/